Jessica Vaughn, Ph.D.

Jessica Vaughn, Ph.D.

Wiley Rein LLP

Contact
View Bio
RSS

Latest Posts › Center for Biologics Evaluation and Research (CBER)

Share:

The End of an Era: FDA Announces Disposition Plans for COVID-19 Related Guidance Documents

The COVID-19 pandemic presented the U.S. Food and Drug Administration (FDA or Agency) with a monumental task of shifting its operations and the way it approached the regulation of critical drugs, medical devices, and biologic...more

3/17/2023  /  CDRH , Center for Biologics Evaluation and Research (CBER) , Center for Drug Evaluation and Research (CDER) , Clinical Trials , Coronavirus/COVID-19 , Food and Drug Administration (FDA) , Medical Devices , Personal Protective Equipment , Public Health Emergency
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide